Roadblocks confronting widespread dissemination and deployment of Organs on Chips
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Organ on Chip platforms hold significant promise as alternatives to animal models or traditional cell cultures, both of which poorly recapitulate human pathophysiology and human level responses. Within the last 15 years, we have witnessed seminal scientific developments from academic laboratories, a flurry of startups and investments, and a genuine interest from pharmaceutical industry as well as regulatory authorities to translate these platforms. This Perspective identifies several fundamental design and process features that may act as roadblocks that prevent widespread dissemination and deployment of these systems, and provides a roadmap to help position this technology in mainstream drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Further, they typically employ polydimethylsiloxane (PDMS), which can absorb gases and small molecules like drugs, and hence, is not a preferable material for developing organs on chips meant for disease modeling and drug discovery.17”
From Retinal organoid chip: engineering a physiomimetic oxygen gradient for optimizing long term culture of human retinal organoids (2025) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250 · cited 2×
“Following the landmark publication of Lung on a Chip in 2010, and robust support from funding agencies, Organ on Chip technology has becomeone of the fastestgrowing areas in bioengineering 12 .”
Bhatia, S. N., & Ingber, D. E. (2014) · Nature Biotechnology · doi:10.1038/nbt.2989 · Cited by 3,305
Microfluidic devices fabricated in Poly(dimethylsiloxane) for biological studies
Sia, S. K., & Whitesides, G. M. (2003) · ELECTROPHORESIS · doi:10.1002/elps.200305584 · Cited by 1,717 · cited 1×
“PDMS has become the material of choice for Organs on Chips due to properties that make it suitable for biological applications, such as low cytotoxicity, optical transparency, gas permeability, and established fabrication methods 64,65 .”
Human organs-on-chips for disease modelling, drug development and personalized medicine
Ingber, D. E. (2022) · Nature Reviews Genetics · doi:10.1038/s41576-022-00466-9 · Cited by 1,589 · cited 4×
“Additionally, Organ on Chip devices are designed to utilize an ever-growing array of analytic techniques to assess the functionality and biomechanics of the tissues cultured within them, such as live-cell imaging, analyte collection, and electrophysiological readouts 2,3,16,29 – 32 .”
InfluentialEstimation of clinical trial success rates and related parameters
Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585 · cited 1×
“Despite this huge investment of time and money, the clinical success rate of drug approval stands between 10 and 20% 52,53 .”
Becker, H. (2002) · Talanta · doi:10.1016/s0039-9140(01)00594-x · Cited by 1,187
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
A guide to the organ-on-a-chip
Leung, C. M., de Haan, P., Ronaldson-Bouchard, K., Kim, G.-A., Ko, J., Rho, H. S., Chen, Z., Habibovic, P., Jeon, N. L., Takayama, S., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00118-6 · Cited by 1,116
Organs-on-chips: into the next decade
Low, L. A., Mummery, C., Berridge, B. R., Austin, C. P., & Tagle, D. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0079-3 · Cited by 1,029 · cited 1×
“Therefore, a systems engineering approach is necessary to design and manage the various components required for a practical platform 80 – 82 .”
Materials for Microfluidic Chip Fabrication
Ren, K., Zhou, J., & Wu, H. (2013) · Accounts of Chemical Research · doi:10.1021/ar300314s · Cited by 974
Cited by
Advances in 3D Organoids and Organ‐on‐a‐Chip Systems for Biomedical Research
Sakthivel, V., Dharshan, S. S., Namasivayam, S. K. R., & Arockiaraj, J. (2026) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbma.70028 · Cited by 56
Advanced In Vitro Models for Preclinical Drug Safety: Recent Progress and Prospects
Nair, D. G., & Weiskirchen, R. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb47010007 · Cited by 53
A review of organ-on-chip fabrication methods: From early developments to overcoming inert barriers
Olaizola‐Rodrigo, C., Bayona, C., Oliván, S., & Monge, R. (2025) · iScience · doi:10.1016/j.isci.2025.113992 · Cited by 35
“125 Almost all PDMS-based OOC platforms discussed above retain a separating membrane between compartments, preventing direct tissue-tissue contact and limiting intercellular cross-talk (e.g., Figures 4B and 4C, and 4E).”
Harnessing Intelligence from Brain Cells In Vitro
Kagan, B. J., Habibollahi, F., Watmuff, B., Azadi, S. A., Doensen, F., Loeffler, A., Byun, S. H., Servais, B., Desouza, C., Abu-Bonsrah, K. D., et al. (2025) · The Neuroscientist · doi:10.1177/10738584251321438 · Cited by 32
Lei, Y., Zhang, Y., Zhou, L., Zhou, Z., Rothbauer, M., Bai, L., Xu, J., Xie, D., Mobasheri, A., Zhang, X., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2025.10.013 · Cited by 32
“This act opened the door for the expanded use of NAMs like organoids and OoCs, accelerating the translation of these innovative technologies into clinical applications and potentially revolutionizing drug development and regulatory processes [110].”
Metadata
- Authors
- Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A.
- Affiliations
- University of Miami (US)
- Corresponding author
- Agarwal, Ashutosh
- Venue
- Nature Communications
- Published
- 2024-06-15
- Volume
- 15
- Issue
- 1
- Pages
- 5118-5118
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC11180125
- OpenAlex
- W4399704632
- Cited by
- 74
- References
- 93
- Citations by year
- 2026: 45 · 2025: 27 · 2024: 2
- FWCI
- 2.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (F31DK118860, UH3DK122638, F31DK132916)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (U01CA233363)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Engineering › Biomedical Engineering › Microfluidic and Capillary Electrophoresis Applications
- Keywords
- organ-on-a-chip, microfluidic organ models, alternative to animal models, 3D cell culture, drug discovery, translational barriers, technology deployment, human pathophysiology, regulatory acceptance
- MeSH terms
- Microphysiological Systems, Animals, Drug Industry, Humans, Drug Discovery, Lab-On-A-Chip Devices
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Roadblocks confronting widespread dissemination and deployment of Organs on Chips. https://app.cochat.ai/papers/10.1038/s41467-024-48864-3
- The paper
- Alver, C. G., Drabbe, E., Ishahak, M., & Agarwal, A. (2024). Roadblocks confronting widespread dissemination and deployment of Organs on Chips. Nature Communications. https://doi.org/10.1038/s41467-024-48864-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.